Daratumumab provides transient response of antibody mediated rejection post pediatric orthotopic heart transplantation.

Fenton, Matthew; Shaw, Kathryn; Murchan, Helene; Duignan, Sophie; Dunne, Esme; McMahon, Colin J

Fenton, Matthew; Shaw, Kathryn; Murchan, Helene; Duignan, Sophie; Dunne, Esme; McMahon, Colin J.

Afiliação

Fenton M; Great Ormond Street Hospital for Children NHS Foundation Trust and Cardiothoracic Transplant Unit, London, UK.
Shaw K; Pharmacy Department, Children's Health Ireland, Dublin, Ireland.
Murchan H; Department of Paediatric Cardiology, CHI Crumlin, Dublin, Ireland.
Duignan S; Department of Paediatric Cardiology, CHI Crumlin, Dublin, Ireland.
Dunne E; Department of Paediatric Cardiology, CHI Crumlin, Dublin, Ireland.
McMahon CJ; Department of Paediatric Cardiology, CHI Crumlin, Dublin, Ireland; School of Medicine, University College Dublin, Belfield, Ireland; School of Health Professions Education, Maastricht University, Maastricht, The Netherlands. Electronic address: cmcmahon992004@yahoo.com.

J Heart Lung Transplant ; 41(10): 1529-1530, 2022 10.

Article em En | MEDLINE | ID: mdl-35864003

Assuntos

Transplante de Coração; Anticorpos Monoclonais/uso terapêutico; Criança; Rejeição de Enxerto/prevenção & controle; Transplante de Coração/efeitos adversos; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Coração Limite: Child / Humans Idioma: En Revista: J Heart Lung Transplant Assunto da revista: CARDIOLOGIA / TRANSPLANTE Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google